NYSE:SENS Senseonics (SENS) Stock Price, News & Analysis → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free sens Stock Alerts $0.44 +0.02 (+4.88%) (As of 04:10 PM ET) Add Compare Share Share Today's Range$0.42▼$0.4750-Day Range$0.40▼$0.7352-Week Range$0.38▼$1.05Volume1.48 million shsAverage Volume2.43 million shsMarket Capitalization$231.44 millionP/E RatioN/ADividend YieldN/APrice Target$1.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Senseonics alerts: Email Address Senseonics MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside186.7% Upside$1.25 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.13) to ($0.11) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.43 out of 5 starsMedical Sector883rd out of 918 stocksProcess Control Instruments Industry12th out of 12 stocks 3.0 Analyst's Opinion Consensus RatingSenseonics has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.Amount of Analyst CoverageSenseonics has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SENS. Previous Next 0.0 Dividend Strength Dividend YieldSenseonics does not currently pay a dividend.Dividend GrowthSenseonics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SENS. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Senseonics this week, compared to 1 article on an average week.Search InterestOnly 5 people have searched for SENS on MarketBeat in the last 30 days. This is a decrease of -69% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Senseonics to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Senseonics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.90% of the stock of Senseonics is held by insiders.Percentage Held by InstitutionsOnly 12.36% of the stock of Senseonics is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Senseonics are expected to grow in the coming year, from ($0.13) to ($0.11) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Senseonics is -3.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Senseonics is -3.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSenseonics has a P/B Ratio of 6.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... About Senseonics Stock (NYSE:SENS)Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.Read More SENS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SENS Stock News HeadlinesApril 29, 2024 | finance.yahoo.comContinuous Glucose Monitoring Market to hit USD 20 Bn by 2032, says Global Market Insights Inc.April 24, 2024 | americanbankingnews.comSenseonics (NYSE:SENS) Trading Up 7.8%April 29, 2024 | InvestorPlace (Ad)Have You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...April 4, 2024 | finance.yahoo.comArtificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies 2024April 3, 2024 | finance.yahoo.comComprehensive Market Analysis Reveals Significant Insights into the Insulin Pumps and Continuous Glucose Monitors Market Through 2033March 12, 2024 | prnewswire.comSAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMSMarch 8, 2024 | businesswire.comSenseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for DiabetesMarch 6, 2024 | businesswire.comSenseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services ConferenceApril 29, 2024 | InvestorPlace (Ad)Have You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...March 2, 2024 | finance.yahoo.comSenseonics Holdings, Inc. (AMEX:SENS) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | msn.comSenseonics slips amid concerns over demand for EversenseMarch 1, 2024 | finance.yahoo.comQ4 2023 Senseonics Holdings Inc Earnings CallFebruary 29, 2024 | msn.comSenseonics GAAP EPS of -$0.03 beats by $0.01, revenue of $8M beats by $0.38MFebruary 29, 2024 | washingtonpost.comSenseonics: Q4 Earnings SnapshotFebruary 29, 2024 | finance.yahoo.comSenseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 29, 2024 | businesswire.comSenseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 28, 2024 | markets.businessinsider.comHere's what to expect from Senseonics's earningsFebruary 25, 2024 | finance.yahoo.comSENS Jan 2026 1.500 putFebruary 22, 2024 | benzinga.comSenseonics Holdings Stock (AMEX:SENS), Short Interest ReportFebruary 21, 2024 | ca.finance.yahoo.comSENS Mar 2024 0.500 callFebruary 15, 2024 | finance.yahoo.comSenseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern TimeFebruary 15, 2024 | businesswire.comSenseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern TimeFebruary 12, 2024 | finance.yahoo.comMEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEMFebruary 6, 2024 | finance.yahoo.comPHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes CareJanuary 23, 2024 | money.usnews.comSenseonics Holdings IncJanuary 4, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Senseonics Holdings (SENS)December 28, 2023 | morningstar.comSenseonics Holdings Inc SENSSee More Headlines Receive SENS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/29/2024Today4/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Process control instruments Sub-IndustryN/A Current SymbolNYSE:SENS Previous SymbolNYSE:SENS CUSIPN/A CIK1616543 Webwww.senseonics.com Phone301-515-7260Fax301-515-0988Employees132Year FoundedN/APrice Target and Rating Average Stock Price Target$1.25 High Stock Price Target$2.00 Low Stock Price Target$0.50 Potential Upside/Downside+187.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-60,390,000.00 Net Margins-270.13% Pretax Margin-269.73% Return on Equity-146.90% Return on Assets-49.81% Debt Debt-to-Equity Ratio1.15 Current Ratio7.53 Quick Ratio7.03 Sales & Book Value Annual Sales$22.39 million Price / Sales10.30 Cash FlowN/A Price / Cash FlowN/A Book Value$0.07 per share Price / Book6.21Miscellaneous Outstanding Shares530,820,000Free Float510,116,000Market Cap$230.64 million OptionableN/A Beta0.87 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Timothy T. Goodnow Ph.D. (Age 62)President, CEO & Director Comp: $1.34MDr. Mukul Jain (Age 51)Chief Operating Officer Comp: $767.65kMr. Kenneth L. Horton (Age 57)General Counsel & Corporate Development Advisor Comp: $702.33kDr. Francine Ratner Kaufman M.D. (Age 72)Chief Medical Officer & Director Mr. Frederick T. Sullivan (Age 42)CFO, Secretary & Treasurer Key CompetitorsMesa LaboratoriesNASDAQ:MLABPrelude TherapeuticsNASDAQ:PRLDMerrimack PharmaceuticalsNASDAQ:MACKG1 TherapeuticsNASDAQ:GTHXFoghorn TherapeuticsNASDAQ:FHTXView All CompetitorsInsiders & InstitutionsNewbridge Financial Services Group Inc.Sold 304,230 shares on 4/24/2024Ownership: 0.026%RPO LLCBought 65,573 shares on 2/12/2024Ownership: 0.012%Sharon LarkinSold 30,889 sharesTotal: $18,842.29 ($0.61/share)Douglas A RoederBought 300,000 shares on 8/30/2023Total: $162,000.00 ($0.54/share)View All Insider TransactionsView All Institutional Transactions SENS Stock Analysis - Frequently Asked Questions Should I buy or sell Senseonics stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SENS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SENS, but not buy additional shares or sell existing shares. View SENS analyst ratings or view top-rated stocks. What is Senseonics' stock price target for 2024? 2 Wall Street research analysts have issued 1-year target prices for Senseonics' shares. Their SENS share price targets range from $0.50 to $2.00. On average, they predict the company's share price to reach $1.25 in the next twelve months. This suggests a possible upside of 186.7% from the stock's current price. View analysts price targets for SENS or view top-rated stocks among Wall Street analysts. How have SENS shares performed in 2024? Senseonics' stock was trading at $0.5701 at the beginning of the year. Since then, SENS shares have decreased by 23.5% and is now trading at $0.4360. View the best growth stocks for 2024 here. How were Senseonics' earnings last quarter? Senseonics Holdings, Inc. (NYSE:SENS) released its quarterly earnings data on Thursday, February, 29th. The company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.01. The company had revenue of $8 million for the quarter, compared to analysts' expectations of $7.62 million. Senseonics had a negative trailing twelve-month return on equity of 146.90% and a negative net margin of 270.13%. What ETF holds Senseonics' stock? Global X Telemedicine & Digital Health ETF holds 510,559 shares of SENS stock, representing 0.44% of its portfolio. What guidance has Senseonics issued on next quarter's earnings? Senseonics updated its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $22.0 million-$22.0 million, compared to the consensus revenue estimate of $21.8 million. When did Senseonics IPO? Senseonics (SENS) raised $45 million in an initial public offering on Friday, March 18th 2016. The company issued 15,800,000 shares at a price of $2.85 per share. Leerink Partners, Canaccord Genuity and Raymond James served as the underwriters for the IPO and BTIG was co-manager. Who are Senseonics' major shareholders? Senseonics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Newbridge Financial Services Group Inc. (0.03%). Insiders that own company stock include Anthony R Raab, Douglas A Roeder, Douglas S Prince, Edward Fiorentino, Francine Kaufman, Mirasol Panlilio, Mukul Jain, Nick B Tressler, Sharon Larkin, Stephen P Defalco and Timothy T Goodnow. View institutional ownership trends. How do I buy shares of Senseonics? Shares of SENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:SENS) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap Profits4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senseonics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
